Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? Reply to Zhou S, Li D, Zhou Y [letter]
暂无分享,去创建一个
[1] Da Li,et al. Management of nicotinamide N-methyltransferase overexpression: inhibit the enzyme or reduce nicotinamide intake? , 2015, Diabetologia.
[2] A. Tönjes,et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance , 2015, Diabetologia.
[3] Alexander S. Banks,et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity , 2014, Nature.
[4] S. Schuster,et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. , 2013, Nature chemical biology.
[5] Yu Cao,et al. Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats , 2013, British Journal of Nutrition.
[6] B. Cravatt,et al. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink , 2013, Nature chemical biology.
[7] Wuping Sun,et al. B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study , 2010, BMC public health.
[8] Chang-Bin Sun,et al. Nicotinamide overload may play a role in the development of type 2 diabetes. , 2009, World journal of gastroenterology.
[9] R. Zechner,et al. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. , 2009, Atherosclerosis.
[10] R. Cox,et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.
[11] A. Chang,et al. Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance , 2006 .
[12] S. Kahn,et al. Nicotinamide's Effects on Glucose Metabolism in Subjects at Risk For IDDM , 1996, Diabetes.
[13] N. Pla. Chronic niacin overload may be involved in the increased prevalence of obesity in US children , 2010 .
[14] A. Chang,et al. Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[15] R. Bergman,et al. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. , 1989, Diabetes.